— Reaffirms fiscal year 2020 guidance range for non-GAAP EPS of $4.85 – $5.10.
— Agrees to resolve all pending and potential opioid lawsuits by states and political subdivisions, which includes payment of up to $5.56 billion over 18 years.
— CAH shares were up 4% immediately following the announcement.
